VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO GI 2021 | Updates in the use of neratinib in fibrolamellar carcinoma and biliary tract cancer

Ghassan Abou-Alfa, MD, Memorial Sloan-Kettering Cancer Center, New York City, NY, updates us on the use of neratinib in both fibrolamellar carcinoma and biliary tract cancer, the latter of which where neratinib was evaluated in combination with immune checkpoint blockade.This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter